Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:10:37 GMT 2023
by
admin
on
Sat Dec 16 00:10:37 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
953A26OA1Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
48090
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NCI_THESAURUS |
C29726
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NDF-RT |
N0000007767
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NDF-RT |
N0000175958
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
851921
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
WHO-VATC |
QR05CB13
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
616617
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NDF-RT |
N0000008867
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NDF-RT |
N0000007956
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
WHO-ATC |
R05CB13
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
447114
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
439614
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
||
|
NDF-RT |
N0000007767
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m4177
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
7167
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
DB00003
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201431
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
100000080786
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
143831-71-4
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
337623
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | RxNorm | ||
|
5135
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
Dornase Alfa
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
DORNASE ALFA
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
953A26OA1Y
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
SUB06373MIG
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
EE-68
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
C81664
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY | |||
|
132053-08-8
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
ALTERNATIVE | |||
|
953A26OA1Y
Created by
admin on Sat Dec 16 00:10:37 GMT 2023 , Edited by admin on Sat Dec 16 00:10:37 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_173 | 1_209 |
1_101 | 1_104 |
Glycosylation Type | MAMMALIAN |
Glycosylation Link Type | Site |
---|---|
N | 1_18 |
N | 1_106 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|